Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2465 posts found.

Domainex opens new Biology Centre of Excellence in Cambridge, UK

February 14, 2024 Business Services Pharmacy, domainex, facility

Domainex has announced that it has opened a new Biology Centre of Excellence at the Unity Campus at Pampisford, Cambridge, …

Jazz Pharmaceuticals enters agreement to acquire rights to KRAS inhibitor programme from Redx Pharma

February 7, 2024 Business Services Pharmacy, RedX Pharma, acquisition, jazz pharmaceuticals

Jazz Pharmaceuticals and Redx Pharma have announced that the companies have signed a definitive agreement under which Jazz will acquire …

Novartis to acquire MorphoSys AG for €2.7bn

February 6, 2024 Business Services Novartis, Pharmacy, acquisition, morphosys

Novartis has announced that it has entered an agreement to acquire MorphoSys AG for €2.7bn, or €68 per share. The …

Zuellig Pharma acquires Cialis and Alimta from Eli Lilly in certain ASEAN markets

February 5, 2024 Business Services Cialis, Eli Lilly, Pharmacy, Zuellig Pharma, acquisition

Zuellig Pharma has announced that it has completed the acquisition of two brands Cialis (Tadalafil) and Alita (Pemetrexed) from Eli …

Regeneron forms Regeneron Cell Medicines with acquisition of 2seventy bio

January 31, 2024 Business Services 2seventy bio, Pharmacy, Regeneron, Regeneron Cell Medicines, acquisition

Regeneron Pharmaceuticals has announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio to acquire the …

Oxford Biomedica acquires ABL Europe for €15m

January 30, 2024 Business Services ABL Europe, Oxford BioMedica, Pharmacy, acquisition

Oxford Biomedica has announced that it has completed the acquisition of ABL Europe from Institut Mérieux. This follows announcements on …

Futura Medical appoints Roy Davis as non-executive director

January 25, 2024 Business Services Futura Medical, Roy Davis, appointment, non-executive director

Futura Medical has announced the appointment of Roy Davis as non-executive director effective immediately. Roy has extensive commercial experience in …

Cellular Origins appoints Peter Crossley as chief operating officer

January 25, 2024 Business Services Cellular Origins, Peter Crossley, appointment, chief operating officer

Cellular Origins, a TTP Company, has announced that it has appointed Peter Crossley as chief operating officer (COO). Peter brings …

BenevolentAI appoints Dr Joerg Moeller as CEO

January 25, 2024 Business Services BenevolentAI, CEO, Dr Joerg Moeller, appointment

BenevolentAI has announced that it has appointed Dr Joerg Moeller MD PhD as chief executive officer and executive board member …

Sanofi to acquire Inhibrx for approximately $1.7bn

January 23, 2024 Business Services Inhibrx, Rare Diseases, Sanofi, acquisition

Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for Sanofi to acquire Inhibrx following …

Qlucore and Sahlgrenska Hospital sign agreement for ALL diagnosis software

January 17, 2024 Business Services Oncology, Qlucore, Sahlgrenska Hospital, acute lymphoblastic leukaemia, leukaemia

Qlucore has announced that it has entered into an agreement with Sahlgrenska Hospital, in Gothenberg, Sweden. This agreement means the …

Merck to acquire Harpoon Therapeutics for approximately $680m

January 10, 2024 Business Services Harpoon Therapeutics, MSD, Merck, Oncology, acquisition

Merck (known as MSD outside of the US and Canada) and Harpoon Therapeutics have announced that they have entered a …

GSK to acquire Aiolos Bio for $1bn

January 9, 2024 Business Services Aiolos Bio, GSK, Pharmacy, acquisition

GSK and Aiolos Bio have announced that they have entered into an agreement for GSK to acquire Aiolos for an …

Calypso Biotech to be acquired by Novartis for $250m

January 8, 2024 Business Services Calypso Biotech, Immunology, Novartis, acquisition

Calypso Biotech has announced that it has entered into an agreement to be acquired by Novartis. The company’s shareholders will …

AstraZeneca to acquire Icosavax for up to $1.1bn

December 12, 2023 Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …
The Gateway to Local Adoption Series

Latest content